Private Placements

Apr 26, 2001, 01:00 ET from Current Technology Corporation

    VANCOUVER, British Columbia, April 26 /PRNewswire/ -- The following was
 issued today by Anne Kramer, President of Current Technology Corporation:
 
     Current Technology Corporation (the "Company") has agreed to issue
 2,814,000 units in the capital of the Company for $140,730 (all funds USD).
 Each unit consists of one common share and one share purchase warrant.  Each
 warrant entitles the holder to purchase one additional common share at
 $0.05 up to and including January 31, 2006.
     In a separate transaction, the Company has issued a convertible promissory
 note in the amount of $10,000, which matures on March 9, 2005.  The lender may
 convert the principal in 400,000 warrants.  Each warrant entitles the lender
 to purchase one additional common share at $0.20 per share any time prior to
 the maturity date.  Interest shall not be payable.
     Current Technology Corporation is the developer of ETG
 (Electrotrichogenesis), a patented electrotherapeutic device that provides a
 clinically proven medical treatment for hair loss, in suitable candidates both
 male and female.  ETG treatments are presently available in several countries
 around the world.
 
                      MAKE YOUR OPINION COUNT - Click Here
                http://tbutton.prnewswire.com/prn/11690X84437718
 
 

SOURCE Current Technology Corporation
    VANCOUVER, British Columbia, April 26 /PRNewswire/ -- The following was
 issued today by Anne Kramer, President of Current Technology Corporation:
 
     Current Technology Corporation (the "Company") has agreed to issue
 2,814,000 units in the capital of the Company for $140,730 (all funds USD).
 Each unit consists of one common share and one share purchase warrant.  Each
 warrant entitles the holder to purchase one additional common share at
 $0.05 up to and including January 31, 2006.
     In a separate transaction, the Company has issued a convertible promissory
 note in the amount of $10,000, which matures on March 9, 2005.  The lender may
 convert the principal in 400,000 warrants.  Each warrant entitles the lender
 to purchase one additional common share at $0.20 per share any time prior to
 the maturity date.  Interest shall not be payable.
     Current Technology Corporation is the developer of ETG
 (Electrotrichogenesis), a patented electrotherapeutic device that provides a
 clinically proven medical treatment for hair loss, in suitable candidates both
 male and female.  ETG treatments are presently available in several countries
 around the world.
 
                      MAKE YOUR OPINION COUNT - Click Here
                http://tbutton.prnewswire.com/prn/11690X84437718
 
 SOURCE  Current Technology Corporation